Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 6/1/14  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. John R. Manthei

Wrong John R. Manthei?

Partner

Local Address: WASHINGTON, District of Columbia, United States
Latham & Watkins LLP
633 West Fifth Street Suite 4000
Los Angeles, California 90071
United States

Company Description: Latham & Watkins LLP is a global law firm with more than 1,500 attorneys in 22 offices, including Boston, Brussels, Chicago, Frankfurt, Hamburg, Hong Kong, London,...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • JD
    University of Wisconsin Law School
  • BA
    Miami University
  • JD
    University of Wisconsin
  • law degree
    University of Wisconsin Law School
75 Total References
Web References
Latham & Watkins LLP - About Us - News - Medicis Pharmaceutical Advised in its $2.6 Billion Acquisition by Valeant
www.latham.com, 1 June 2014 [cached]
Advice was also provided on antitrust matters by partner Michael Egge with associate Jason Cruise in Washington D.C.: on benefits and compensation matters by partner Jim Barrall in Los Angeles with associate Carol Samaan in Orange County; on litigation matters by partners David Schindler in Los Angeles and Michele Johnson in Orange County; on regulatory matters by partner John Manthei with associate Elizabeth Richards in Washington D.C.; on intellectual property matters by partner Judith Hasko in Silicon Valley; on environmental matters by partner Christopher Norton in Orange County; and on tax matters by partner Nicholas DeNovio in Washington D.C.
...
John R. Manthei
BayBio  | BayBio
www.baybio.org, 19 June 2011 [cached]
John R. Manthei Partner, Latham & Watkins
John R. Manthei is a partner in the Washington, D.C. office of Latham & Watkins and serves as Global Co-Chair and Washington, D.C. Department Chair of the Healthcare and Life Sciences Practice. His practice focuses on regulatory matters involving the Food and Drug Administration (FDA) for the medical device, pharmaceutical, biotechnology, food and dietary supplement industries. Mr. Manthei's practice includes assisting clients with all aspects of the FDA-regulated product life cycle, including, among others: pre-market development; FDA product submissions; development of market exclusivity strategies; drafting and negotiation of both US and international clinical trial agreements; FDA and Federal Trade Commission (FTC) regulation of marketing and promotion of products; Quality System Regulation and Good Manufacturing Practice requirements (including assisting in third-party audits and drafting SOPs); FDA inspections; recalls; FDA and DEA export and import requirements; and civil and criminal compliance and enforcement. Prior to joining Latham, Mr. Manthei served as Majority Counsel for the US House of Representatives' Committee on Energy and Commerce (1998-2000). In this capacity, he counseled the Full Commerce Committee Chairman; the Health and Environment and Oversight and Investigations Subcommittee Chairmen; as well as the House Leadership on matters relating to the FDA and legislation concerning the Federal Food, Drug and Cosmetic Act, the Public Health Service Act, and the Controlled Substances Act. Since 2000, Mr. Manthei has represented the pharmaceutical, biotechnology and medical device industries as counsel in nearly every major FDA legislative initiative. He has also testified before Congress on several occasions involving FDA and DEA regulatory and enforcement matters. Mr. Manthei serves as outside FDA counsel to the Medical Device Manufacturers Association (MDMA), is a member of the Food & Drug Law Institute's Advisory Committee for Drugs and Biologics. Mr. Manthei has authored numerous articles and has been a featured speaker and lecturer on FDA regulatory and enforcement matters at events sponsored by the Pharmaceutical Research and Manufacturers Association (PhRMA), the Biotechnology Industry Organization (BIO), AdvaMed, MDMA, BioCom, BayBio, the Food and Drug Law Institute (FDLI), the American Health Lawyers Association (AHLA), GMA, Harvard University, Stanford University and MIT, among others.
About FDLI - Committees
www.fdli.org, 4 Dec 2009 [cached]
John Manthei, Latham & Watkins
SpeakerBios
www.medicaldevices.org, 25 Nov 2009 [cached]
John Manthei, Partner Latham & Watkins John Manthei is a partner in the firm's Washington, D.C. office and the global co-chair of the firm's Health Care and Life Sciences Practice. Mr. Manthei's practice focuses on regulatory matters involving the FDA for the medical device, pharmaceutical and biotechnology industries. His practice includes assisting clients with all aspects of the FDA-regulated product life cycle in both the US and the EU. Prior to joining Latham, Mr. Manthei served as Majority Counsel for the US House of Representatives' Committee on Commerce. He also served as the primary congressional staff contact in the House with the FDA Commissioner's Office and Center Directors, in developing FDA policy. Currently, Mr. Manthei serves as outside FDA counsel to MDMA and is a member of the Food & Drug Law Institute's Advisory Committee for Drugs and Biologics. In 2006, Mr. Manthei was named by Washingtonian Magazine one of the top "40 Lawyers under 40."
John Manthei Partner, ...
www.medicaldevices.org, 25 Nov 2009 [cached]
John Manthei Partner, Latham and Watkins John Manthei is a partner in the firm's Washington, D.C. office and the global co-chair of the firm's Health Care and Life Sciences Practice. Mr. Manthei's practice focuses on regulatory matters involving the FDA for the medical device, pharmaceutical and biotechnology industries. His practice includes assisting clients with all aspects of the FDA-regulated product life cycle in both the US and the EU. Prior to joining Latham, Mr. Manthei served as Majority Counsel for the US House of Representatives' Committee on Commerce. He also served as the primary congressional staff contact in the House with the FDA Commissioner's Office and Center Directors, in developing FDA policy. Currently, Mr. Manthei serves as outside FDA counsel to MDMA and is a member of the Food & Drug Law Institute's Advisory Committee for Drugs and Biologics. In 2006, Mr. Manthei was named by Washingtonian Magazine one of the top "40 Lawyers under 40."
Other People with the name "Manthei":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304